Humoral Immunity in Myasthenia Gravis: Relationship to Disease Severity and Steroid Treatment

R. J. Bradley; D. Dwyer; B. J. Morley; G. Robinson; G. E. Kemp; S. J. Oh

doi:10.1016/S0079-6123(08)64656-7

Humoral Immunity in Myasthenia Gravis: Relationship to Disease Severity and Steroid Treatment

R. J. Bradley, D. Dwyer, B. J. Morley, G. Robinson, G. E. Kemp, S. J. Oh

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

In order to determine the role of humoral factors in myasthenia gravis (MG) the anti-acetylcholine receptor antibody was measured in the sera of a series of patients and controls. A radioimmunoassay and a toxin-inhibition assay were used to assess the interaction of the autoantibody with receptor purified from denervated rat muscle. Antibody was detected in 88% of MG patients and was not present in controls. In some patients the antibody was assayed at different time during the course of the disease and after the drug-induced remission of symptoms. Antibody titre was found to increase with the progressive development of muscle weakness but remained very high after muscle strength returned to normal during steroid treatment. It is suggested that autoantibody may be necessary but is not sufficient to account for the pathogenesis of MG.

Original language	English (US)
Pages (from-to)	441-448
Number of pages	8
Journal	Progress in Brain Research
Volume	49
Issue number	C
DOIs	https://doi.org/10.1016/S0079-6123(08)64656-7
State	Published - Jan 1 1979
Externally published	Yes

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

10.1016/S0079-6123(08)64656-7

Fingerprint Dive into the research topics of 'Humoral Immunity in Myasthenia Gravis: Relationship to Disease Severity and Steroid Treatment'. Together they form a unique fingerprint.

Cite this

@article{b6546299d1cb4cfea111a48a367289af,

title = "Humoral Immunity in Myasthenia Gravis: Relationship to Disease Severity and Steroid Treatment",

abstract = "In order to determine the role of humoral factors in myasthenia gravis (MG) the anti-acetylcholine receptor antibody was measured in the sera of a series of patients and controls. A radioimmunoassay and a toxin-inhibition assay were used to assess the interaction of the autoantibody with receptor purified from denervated rat muscle. Antibody was detected in 88% of MG patients and was not present in controls. In some patients the antibody was assayed at different time during the course of the disease and after the drug-induced remission of symptoms. Antibody titre was found to increase with the progressive development of muscle weakness but remained very high after muscle strength returned to normal during steroid treatment. It is suggested that autoantibody may be necessary but is not sufficient to account for the pathogenesis of MG.",

author = "Bradley, {R. J.} and D. Dwyer and Morley, {B. J.} and G. Robinson and Kemp, {G. E.} and Oh, {S. J.}",

year = "1979",

month = jan,

day = "1",

doi = "10.1016/S0079-6123(08)64656-7",

language = "English (US)",

volume = "49",

pages = "441--448",

journal = "Progress in Brain Research",

issn = "0079-6123",

publisher = "Elsevier",

number = "C",

}

TY - JOUR

T1 - Humoral Immunity in Myasthenia Gravis

T2 - Relationship to Disease Severity and Steroid Treatment

AU - Bradley, R. J.

AU - Dwyer, D.

AU - Morley, B. J.

AU - Robinson, G.

AU - Kemp, G. E.

AU - Oh, S. J.

PY - 1979/1/1

Y1 - 1979/1/1

N2 - In order to determine the role of humoral factors in myasthenia gravis (MG) the anti-acetylcholine receptor antibody was measured in the sera of a series of patients and controls. A radioimmunoassay and a toxin-inhibition assay were used to assess the interaction of the autoantibody with receptor purified from denervated rat muscle. Antibody was detected in 88% of MG patients and was not present in controls. In some patients the antibody was assayed at different time during the course of the disease and after the drug-induced remission of symptoms. Antibody titre was found to increase with the progressive development of muscle weakness but remained very high after muscle strength returned to normal during steroid treatment. It is suggested that autoantibody may be necessary but is not sufficient to account for the pathogenesis of MG.

AB - In order to determine the role of humoral factors in myasthenia gravis (MG) the anti-acetylcholine receptor antibody was measured in the sera of a series of patients and controls. A radioimmunoassay and a toxin-inhibition assay were used to assess the interaction of the autoantibody with receptor purified from denervated rat muscle. Antibody was detected in 88% of MG patients and was not present in controls. In some patients the antibody was assayed at different time during the course of the disease and after the drug-induced remission of symptoms. Antibody titre was found to increase with the progressive development of muscle weakness but remained very high after muscle strength returned to normal during steroid treatment. It is suggested that autoantibody may be necessary but is not sufficient to account for the pathogenesis of MG.

UR - http://www.scopus.com/inward/record.url?scp=0018587347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018587347&partnerID=8YFLogxK

U2 - 10.1016/S0079-6123(08)64656-7

DO - 10.1016/S0079-6123(08)64656-7

M3 - Article

C2 - 515441

AN - SCOPUS:0018587347

VL - 49

SP - 441

EP - 448

JO - Progress in Brain Research

JF - Progress in Brain Research

SN - 0079-6123

IS - C

ER -